An autocrine ActivinB mechanism drives TGFβ/Activin signaling in Group 3 medulloblastoma

Medulloblastoma (MB) is a pediatric tumor of the cerebellum divided into four groups. Group 3 is of bad prognosis and remains poorly characterized. While the current treatment involving surgery, radiotherapy, and chemotherapy often fails, no alternative therapy is yet available. Few recurrent genomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Morabito, Morgane, Larcher, Magalie, Cavalli, Florence MG, Foray, Chloé, Forget, Antoine, Mirabal‐Ortega, Liliana, Andrianteranagna, Mamy, Druillennec, Sabine, Garancher, Alexandra, Masliah‐Planchon, Julien, Leboucher, Sophie, Debalkew, Abel, Raso, Alessandro, Delattre, Olivier, Puget, Stéphanie, Doz, François, Taylor, Michael D, Ayrault, Olivier, Bourdeaut, Franck, Eychène, Alain, Pouponnot, Celio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685082/
https://www.ncbi.nlm.nih.gov/pubmed/31328883
http://dx.doi.org/10.15252/emmm.201809830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685082/
https://www.ncbi.nlm.nih.gov/pubmed/31328883
http://dx.doi.org/10.15252/emmm.201809830

Ejemplares similares